Immuno-oncology Drugs Market, By Drug Type (Immune Checkpoint Inhibitors, Monoclonal Antibodies, Cyt

Published Date: | Report Code : HC2067810

X

Immuno-oncology Drugs Market, By Drug Type (Immune Checkpoint Inhibitors, Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, and CAR-T Cell Therapy), By Cancer Type (Non-Small Cell Lung Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Breast Cancer, Ovarian Cancer, Prostate Cancer, Colorectal Cancer, Gastric Cancers, Glioblastoma, and Head & Neck Cancers), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2067810

Status : Upcoming

The Immuno-oncology Drugs Market report points out national and global business prospects and competitive conditions for Immuno-oncology drugs. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for Immuno-oncology drugs. The Immuno-oncology drugs market has been segmented by drug type (immune checkpoint inhibitors, monoclonal antibodies, cytokine-based immunotherapy, cancer vaccines, and car-t cell therapy), by cancer type (non-small cell lung cancer, acute myeloid leukemia, lymphoma, multiple myeloma, breast cancer, ovarian cancer, prostate cancer, colorectal cancer, gastric cancers, glioblastoma, and head & neck cancers). Historical background for the demand of Immuno-oncology drugs has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand Immuno-oncology drugs have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Drug Type:   

  • Immune Checkpoint Inhibitors
  • Monoclonal Antibodies
  • Cytokine-Based Immunotherapy
  • Cancer Vaccines
  • and CAR-T Cell Therapy

By Cancer Type:

  • Non-Small Cell Lung Cancer
  • Acute Myeloid Leukemia, Lymphoma
  • Multiple Myeloma
  • Breast Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Gastric Cancers
  • Glioblastoma
  • and Head & Neck Cancers

By Region:

North America Immuno-oncology Drugs Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Drug Type
  • North America, by Cancer Type

Europe Immuno-oncology Drugs Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Drug Type
  • Europe, by Cancer Type

Asia Pacific Immuno-oncology Drugs Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Drug Type
  • Asia Pacific, by Cancer Type

Middle East & Africa Immuno-oncology Drugs Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Drug Type
  • Middle East & Africa, by Cancer Type

South America Immuno-oncology Drugs Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Drug Type
  • South America, by Cancer Type

Major Companies: Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, AbbVie, Inc., Pfizer Inc., Sanofi S.A., EMD Serono, Inc., Gilead Sciences Inc., Prometheus Therapeutics & Diagnostics, Aduro BioTech, Galena Biopharma, Bavarian Nordic, Celldex Therapeutics, ImmunoCellular Therapeutics, and Incyte.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for Immuno-oncology drugs market on regional and global basis.
  • To identify major segments in Immuno-oncology drugs market and evaluate their market shares and demand.
  • To provide a competitive scenario for the Immuno-oncology drugs market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of Immuno-oncology drugs market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the Immuno-oncology drugs market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the Immuno-oncology drugs market.

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: [email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy